About Conference
This symposium unites multidisciplinary experts from Memorial Sloan Kettering Cancer Center and around the world, spanning specialties such as hematology, nephrology, surgery, pathology, immunology, and bioethics. The organizers will explore critical topics pertaining to the evaluation and management of plasma cell dyscrasia patients being considered for kidney transplantation
Highlights
Updates in MGRS pathology and classification, the latest developments in clone-directed therapy and outcomes, assessing depth of response, updates on transplant biology and immunology, complications of renal transplantation in patients with plasma cell disease, and fair distribution of a scarce resources and role of living donor transplantation.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Relationship-building key to addressing oncologist shortages in rural care
2.
New protein target discovered for childhood medulloblastomas
3.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
4.
Papillary thyroid cancer: New markers offer hope for tailored treatment
5.
Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal
1.
Precision Oncology: Tailoring Cancer Treatment for the Individual
2.
Genetic Screening: A Game Changer in Cancer Prevention
3.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
4.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
5.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
Recommended News For You
1.
3D virtual staining technology enables non-invasive observation of cancer tissue
2.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
3.
Radiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipment
4.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
5.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
Conferences That Might Interest You
Recommended Articles For You
1.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
2.
Surgical Innovation Through Immune-Aware Tumor Resection Strategies
3.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
4.
Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions
5.
Transformative Directions in Hematology in Clinical Decision-Making
Boost Your Knowledge With These Quizzes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge